Comparison of Behavior and Dental Anxiety During Intranasal and Sublingual Midazolam Sedation – A Randomized Controlled Trial

Objectives: The objective of the study was to assess the behavioral effects and the changes in the anxiety level of children after intranasal and sublingual midazolam sedation using Venham's clinical anxiety scale and salivary cortisol level. Study Design: Twenty children aged 3 to 7 years were randomly assigned to Group A (n=10) intranasal or Group B (n=10) sublingual midazolam (0.2mg/kg) sedation. The anxiety levels at various time periods were assessed using Venham clinical anxiety scale and corresponding changes in salivary cortisol levels were assessed before and after the drug administration. The anxiety levels were assessed independently by two pediatric dentists from recorded videos. Wilcoxon signed rank test and Mann Whitney U test were used for statistical analysis using SPSS version 19.0.Results: There was a significant decrease in anxiety level from baseline to 20 minutes after drug administration in group A (p=0.004) and group B (p=0.003). There was no significant change in salivary cortisol levels before and after the drug administration in group A (p=0.07) and group B (p=0.38). Conclusions: Both intranasal and sublingual administration of midazolam was equally effective in reducing the child's anxiety. However, there was no significant difference in the salivary cortisol levels in both groups.

1. Yang C, Zou H, Zou J. Analysis on dental uncooperative behaviors of the first-visit children in clinic. Hua Xi Kou Qiang Yi Xue Za Zhi 29:

501- 4, 2011.

2. Locker D, Liddel A. Correlates of dental anxiety among older adults. J Dent Res 70: 198-203, 1991.

3. Alsarheed M. Children’s Perception of Their Dentists. Eur J Dent 5: 186- 90, 2011.

4. Leal AM, Serra KG, Queiroz RC, Araujo MA, Maia Filho EM. Fear and/or anxiety of children and parents associated with the dental environment. Eur J Paediatr Dent 14: 269-72, 2013.

5. Wright GZ. Behavior management in dentistry for children, WB Saun-ders, Philadelphia; 55-87, 1975.

6. Bozovic D, Racic M, Ivkovic N. Salivary cortisol levels as a biological marker of stress reaction. Med Arch 67: 374-7, 2013.

7. Fortuna A, Alves G, Serralheiro A, Sousa J, Falcao A. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules. Eur J Pharm Biopharm 88: 8-27, 2014.

8. Lam JK, Xu Y, Worsley A, Wong IC. Oral transmucosal drug delivery for pediatric use. Adv Drug Deliv Rev 73: 50-62, 2014.

9. Kapur A, Chawla HS, Gauba K, Goyal A, Bhardwaj N. Effect of oral trans-mucosal midazolam sedation on anxiety levels of 3-4 years old chil-dren during a Class II restorative procedure. Contemp Clin Dent. 5: 334- 9, 2014.

10. Karl HW, Rosenberger JL, Larach MG, Ruffle JM. Transmucosal admin-istration of midazolam for premedication of pediatric patients. Compar-ison of the nasal and sublingual routes. Anesthesiology 78: 885-91, 1993.

11. Venham LL, Gaulin-Kremer E, Munster E, Bengston-Audia D, Cohan J. Interval rating scales for children’s dental anxiety and uncooperative behavior. Pediatr Dent 2: 195-202, 1980.

12. Guinot Jimeno F, Yuste Bielsa S, Cuadros Fernandez C, Lorente Rodrí-guez AI, Mercade Bellido M. Objective and subjective measures for assessing anxiety in paediatric dental patients. Eur J Paediatr Dent 12: 239- 44, 2011.

13. Nater UM, Rohleder N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: Current state of research. Psychoneuroendocrino 34: 486-96, 2009.

14. Prabhakar AR, Marwah N, Raju OS. A comparison between audio and audio visual distraction technique in managing anxious pediatric dental patients. J Indian Soc Pedod Prevent Dent 25: 177–82, 2007.

15. Wilton NCT, Leigh J, Rosen DR, Pandit UA. Preanesthetic sedation of preschool children using intranasal midazolam. Anesthesiology 69: 972–975, 1988.

16. Rey E, De Launay L, Pons G, Murat I, Richard MO, Saint-Maurice C, Olive G. Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration. Eur J Clin Pharmacol 41: 355–357, 1991.

17. Malinovsky JM, Lejus C, Servin F, Lepage JY, Le Normand Y, Testa S, Cozian A, Pinaud M. Plasma concentration of midazolam after IV, nasal or rectal administration in children. BJA 70: 617–620, 1993.

18. Fukuta O, Braham RL, Yanase H, Atsumi N, Kurosu K. The sedative effects of intranasal midazolam administration in the dental treatment of patients with mental disabilities. Part 1 – The effect of a 0.2 mg/kg dose. J Clin Pediatr Dent 17: 231–237, 1993.

19. Rodrigues Gomes SS, Barretobezerra AC, Maia Prado AC. Salivary biomarkers, vital signs and behaviour of pre-school children during their first dental visit. Eur J Paediatr Dent 14: 279-83, 2013.

20. Miller CS, Dembo JB, Falace DA, Kaplan AL. Salivary cortisol response to dental treatment of varying stress. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 79: 436-41, 1995.

21. McCarthy AM, Hanrahan K, Kleiber C, Zimmerman MB, Lutgen-dorf S, Tsalikian E..Normative salivary cortisol values and respon-sivity in children. Appl Nurs Res 22: 54-62, 2009.

22. Hsu AA, von Elten K, Chan D, Flynn T, Walker K, Barnhill J, et al. Char-acterization of the cortisol stress response to sedation and anesthesia in children. J Clin Endocrinol Metab 97: E1830-5, 2012.

23. Kanegane K, Penha SS, Munhoz CD, Rocha RG. Dental anxiety and sali-vary cortisol levels before urgent dental care. J Oral Sci 51: 515-20, 2009.

24. Brand HS. Anxiety and cortisol excretion correlate prior to dental treat-ment. Int Dent J 49: 330–36, 1999.

25. Sadi H, Finkelman M, Rosenberg M. Salivary cortisol, salivary alpha amylase, and the dental anxiety scale. Anesth Prog 60: 46-53, 2013.